Netflix heads into the back half of 2026 with a familiar tension: the stock is recovering, shorts are covering, but the analysts who stayed bullish through Q2 earnings have quietly marked down what they're willing to pay for it.
The clearest story in the data right now is short-side retreat. Short interest dropped sharply at the start of the week, falling roughly 7% from the 100-million-share range it had held through late July to around 93.7 million shares — now 2.2% of the free float. That's a low absolute level, and the direction of travel is firmly down: shorts have shed about 6.7% of their position over the past month. The borrow market reinforces the picture. Availability is essentially unconstrained — the lending pool holds billions of shares relative to the short position, making this one of the most freely borrowable large-caps in the market. Cost to borrow has edged up to 0.60% from a low of 0.23% in late July, more than doubling over that stretch, but at sub-1% it remains trivially cheap. There is no squeeze tension here.
Options positioning is lean on the bearish side, which fits the short-covering narrative. The put/call ratio has drifted to 0.80, slightly below its 20-day average of 0.82 — nearly 1.1 standard deviations on the call-heavy side. That's not a dramatic read, but it points to investors using options for upside participation rather than downside protection. The 52-week range for the PCR runs from 0.76 to 5.18, a reminder of how extreme defensive positioning got at some point in the past year. Today's reading is close to the calm end of that spectrum.
The Street's reaction to Q2 earnings tells the more interesting story. Almost every major firm — Goldman Sachs, JP Morgan, Morgan Stanley, Piper Sandler, Baird — maintained positive ratings but cut price targets sharply in the days after the July 17 report. Goldman moved from $110 to $94. JP Morgan dropped from $118 to $85. Morgan Stanley trimmed from $90 to $83. The cuts were unanimous in direction, even if the bull thesis survived: revenue and free cash flow guidance came down, and the move into ad-supported tiers raised questions about where margins settle long-term. The mean target across the Street now sits around $94, implying roughly 20% upside from the current $78 level — meaningful, but a much narrower gap than the 50%-plus cushion that existed earlier in the year. The analyst recommendation differential factor scores at just 7 out of 100, reflecting how little consensus upgrade momentum remains. EPS surprise scores at 66, suggesting the company still beats estimates more often than not, but EPS momentum over the trailing 30 and 90 days ranks only in the low 40s — the forward earnings revision cycle is treading water.
Insider activity warrants a note of caution. Both Co-CEOs — Ted Sarandos and Greg Peters — sold into the early-August weakness, with Sarandos moving roughly $8.9 million in stock across two consecutive days on August 3-4 and Peters adding $2 million on August 6. The CFO followed with a smaller $700,000 sale on August 10. Net insider activity over 90 days shows more shares issued via awards than sold outright, so the pattern is not a clean distribution signal, but the clustering of executive sales into a down week is worth noting against the current recovery.
The earnings history is unambiguous in one respect: the last two prints each produced immediate drops, with the July 17 report delivering a 9% single-day decline and the subsequent five-day move settling around minus 6%. The next scheduled report lands on October 16. Between now and then, the question for the market is less about whether Netflix can grow and more about whether the advertising tier scales fast enough to offset the guidance resets — and whether the insider selling cluster was routine plan-driven activity or something more deliberate.
See the live data behind this article on ORTEX.
Open NFLX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.